Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death in the U.S., with heart disease accounting for 12% of total healthcare expenditures. While risk estimation tools have been widely recommended, ASCVD mortality rates remain unchanged. This report leverages Veradigm Network EHR data to analyze 10-year ASCVD risk across demographics and geography, offering actionable insights for life science professionals.

What's Inside:

• Insights and trends from the Veradigm Network in ASCVD risk estimation and prevention strategies
• Analysis of 10-year ASCVD risk scores across U.S. populations
• Geographic and demographic variations in cardiovascular risk
• The role of real-world EHR data in understanding ASCVD patterns
• Future innovations, including AI and digital health interventions

Gain valuable insights into ASCVD risk and prevention. Download the report today.